Pharmaceutical R&D in the setting of incomplete European integration

ISSN： 1466-1829

Source： International Journal of the Economics of Business, Vol.11, Iss.2, 2004-07, pp. : 175-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

R&D effects of incomplete procurement contracts

By Goel Rajeev K.

Applied Economics Letters, Vol. 8, Iss. 11, 2001-11 ,pp. : 697-699

Routledge Ltd

Access to resources Recommend Favorite

Corporate strategy R&D and technology transfer in the European pharmaceutical industry: research findings

By Simango Chris C.B.

European Business Review, Vol. 12, Iss. 1, 2000-01 ,pp. : 28-33

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Strategic R&D Location in European Manufacturing Industries

By Belderbos René

Review of World Economics, Vol. 144, Iss. 2, 2008-04 ,pp. : 183-206

Springer Publishing Company

Access to resources Recommend Favorite

Efficiency and its determinants in pharmaceutical industries: ownership, R&D and scale economy

By You Taewoo Chen Xiaoying Holder Mark

Applied Economics, Vol. 42, Iss. 17, 2010-07 ,pp. : 2217-2241

Routledge Ltd

Access to resources Recommend Favorite

Uncertainty and the Dynamics of R&D

By Bloom Nick

The American Economic Review, Vol. 97, Iss. 2, 2007-05 ,pp. : 250-255

American Economic Association

Access to resources Recommend Favorite